Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.

Two hundred and three patients, 148 males and 55 females, who during the last month before admission had experienced at least one reversible cerebral ischemic attack of less than 72 hours duration, were randomly assigned to treatment with either acetylsalicylic acid (ASA) 1000 mg daily (101 patients) or placebo (102 patients). The average follow-up period was 25 months. The two treatment groups were comparable with respect to age, sex, associated diseases, risk factors, number and duration of cerebral ischemic attacks. No statistically significant differences were found between the treatment groups as to the primary end point: stroke or death (ASA group 20.8%, placebo group 16.7%). Occurrence of transient ischemic attacks during the treatment period was not reduced by ASA treatment, whereas there was a trend suggesting fewer myocardial infarctions in the ASA group (5.9%) than in the placebo group (13.7%). The difference, however, was not statistically significant (p = 0.10). We were thus unable to demonstrate any favorable influence of ASA 1000 mg daily in patients with reversible ischemic attacks. This study does not, of course, prove that ASA treatment is ineffective in stroke prevention.

[1]  A. Heltberg,et al.  Long‐term prognosis after transient ischemic attacks , 1981, Acta neurologica Scandinavica.

[2]  J. Stamler.  Aspirin in coronary heart disease , 1980 .

[3]  Lippincott Williams Wilkins,et al.  Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.

[4]  P. Elwood,et al.  ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.

[5]  S. Moncada,et al.  DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN , 1978, The Lancet.

[6]  P. Majerus,et al.  Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin. , 1977, Biochemical and biophysical research communications.

[7]  J. Marx.  Blood clotting: the role of the prostaglandins. , 1977, Science.

[8]  J. Vane,et al.  HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION , 1977, The Lancet.

[9]  J. Gormsen,et al.  PLATELET AGGREGATION AND FIBRINOLYTIC ACTIVITY IN TRANSIENT CEREBRAL ISCHEMIA , 1977, Acta neurologica Scandinavica.

[10]  H. Barnett,et al.  Cerebral Ischemia : The Role of Thrombosis and of Antithrombotic Therapy Study Group on Antithrombotic Therapy , 2005 .

[11]  L. Wilkins.  A Classification and Outline of Cerebrovascular Diseases II , 1975, Stroke.

[12]  G J Roth,et al.  Acetylation of prostaglandin synthase by aspirin. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Dyken,et al.  Differences in the Occurrence of Carotid Transient Ischemic Attacks Associated With Antiplatelet Aggregation Therapy , 1973, Stroke.

[14]  D. Ziegler,et al.  Prognosis in Patients with Transient Ischemic Attacks , 1973, Stroke.

[15]  Elisa T. Lee,et al.  A computer program for comparing K samples with right-censored data. , 1972, Computer programs in biomedicine.

[16]  Aspirin, Platelets and Stroke. Background for a Clinical Trial , 1972 .

[17]  K. V. von Kaulla,et al.  Transient monocular blindness and increased platelet aggregability treated with aspirin , 1972, Neurology.

[18]  J. C. Meadows,et al.  Effect of aspirin in amaurosis fugax. , 1971, Lancet.

[19]  W. S. Fields,et al.  Aspirin, Platelets and Stroke: Background for a Clinical Trial , 1971 .

[20]  J. Marshall.  ANGIOGRAPHY IN THE INVESTIGATION OF ISCHÆMIC EPISODES IN THE TERRITORY OF THE INTERNAL CAROTID ARTERY , 1971 .

[21]  W. Taylor,et al.  Long‐Term Prognosis of Transient Cerebral Ischemic Attacks , 1971, Stroke.

[22]  Tytus Js,et al.  Prognosis in patients with transient ischemic attacks after endarterectomy. , 1970 .

[23]  R. N. Baker,et al.  Transient ischemic strokes , 1966, Neurology.

[24]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[25]  J. O. Irwin,et al.  Statistical Method in Biological Assay , 1953, Nature.

[26]  A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.

[27]  A randomized trial of aspirin and sulfinpyrazone in threatened stroke. , 1978, The New England journal of medicine.

[28]  J. Marshall,et al.  The prognosis of carotid transient ischaemic attacks in patients with normal angiograms. , 1971, Brain : a journal of neurology.

[29]  A Classification and Outline of the Cerebrovascular Diseases , 1958, Neurology.

[30]  C. Millikan,et al.  Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. , 1955, Proceedings of the staff meetings. Mayo Clinic.